Nippi, Incorporated – Trademark Portfolio
Entity Type: 03
Nippi, Incorporated holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include NIPPI, IMATRIX, BIOMASHER, and NIPPI PEPTIDE. The owner is based in Tokyo 120-8601.
1-1-1, Senju Midori-cho, Adachi-ku,
Tokyo 120-8601 , JP
Showing of trademarks Trademarks
Trademark Classifications
Nippi, Incorporated's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Nippi, Incorporated have?
Nippi, Incorporated has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 cancelled.
What trademark classes does Nippi, Incorporated file in?
Nippi, Incorporated files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Nippi, Incorporated's most well-known trademarks?
Nippi, Incorporated's registered trademark portfolio includes well-known marks such as NIPPI, IMATRIX, BIOMASHER, and NIPPI PEPTIDE. These are among 5 currently registered trademarks in the portfolio.
What is Nippi, Incorporated's trademark registration success rate?
Nippi, Incorporated has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.